CMS: Healthcare workers must get first COVID shot by Dec. 5 to continue Medicare, Medicaid participation Surprise COVID-19 antibody sales of $804M help Regeneron trounce expectations in third quarter Alphabet launches AI drug discovery venture built on DeepMind's protein-folding expertise Amgen plays multi-specific matchmaker in quest to tackle the undruggable Shipping delays, supply chain expansions ding Moderna's COVID-19 vaccine business The vast majority of data engineers are burnt out. Those working in healthcare are no exception For pharma marketers, mobile devices reign supreme. But for how long? Siemens posts record year on the back of Varian acquisition, COVID antigen test sales Sangamo's Fabry gene therapy clears early clinical test, firing starting gun on preparations for phase 3 Hologic begins European rollout of AI-powered cervical cancer screening system Bayer poaches Otsuka's chief medical officer Koenen to head up its clinical operations AMIA 2021: Understanding how technology impacts patients and providers Section 32 closes $740M VC fund to back startups at 'intersection of technology and healthcare' Featured Story | By Dave Muoio To continue participating in Medicare and Medicaid, healthcare facilities must have policies in place to ensure all eligible employees receive an initial COVID-19 shot by Dec. 5 and their second by Jan. 4. CMS said that it expects the requirement to reach more than 17 million healthcare workers across the country. read more |
| |
|---|
|
Top Stories By Kevin Dunleavy This summer, Regeneron warned investors not to expect sales of its COViD-19 antibody treatment to the U.S. in the third quarter. But a lucrative deal, signed in mid-September, and a quick supply helped push the company's third quarter revenue beyond expectations. read more By Conor Hale The new Isomorphic Laboratories aims to deliver an “AI-first approach” for tackling biopharma research, with the goal of serving as a commercial partner to drugmakers. read more By Annalee Armstrong Amgen already broke into the “undruggable” market with the approval of Lumakras, but that was just the tip of the iceberg for a pipeline strategy aimed at pursuing targets that were previously considered out-of-reach. read more By Eric Sagonowsky Moderna has been biotech’s biggest growth story in 2021, but the company’s rate of expansion slowed considerably in recent months as shipping delays on its COVID-19 vaccine and a supply chain scale-up took a toll. read more By Anastassia Gliadkovskaya The survey reached 600 data engineers, 100 of whom are managers. Nearly all of them reported experiencing burnout in their daily roles, and experts say healthcare is no exception. read more By Sharon Klahr Coey Pharma marketers take note. Looking for higher click engagement? Run ads Monday and Tuesday. If higher conversion engagement is the goal, though, then it’s Tuesday and Saturday. In terms of the best time—the peak is around 3 p.m. for click engagement and 9 p.m. for conversion, all according to advertising software company Viant Technology, read more By Conor Hale Outside of pandemic-related diagnostic sales, Siemens posted growth of 11.8% compared to the year before, driven by expansions in its core testing, imaging and advanced therapy segments. read more By Nick Paul Taylor Sangamo Therapeutics has posted clinical data on a therapy it hopes will shake up the Fabry disease market. The gene therapy showed encouraging safety and efficacy signs in the small study, prompting Sangamo to start preparations for a phase 3 clinical trial. read more By Andrea Park Altogether, the entire multipart system is designed to be broadly accessible and easily updated and expanded by labs across networks and around the world. read more By Ben Adams As Bayer looks to ramp up its R&D work in the gene therapy space amid a host of biotech tie-ups, the German pharma is tapping Christoph Koenen as its new global head of clinical development and operations in its R&D unit. read more By Anastassia Gliadkovskaya The American Medical Informatics Association is hosting its 2021 Annual Symposium. During its virtual day last week, researchers presented multiple studies on how technology can or does affect the daily lives of patients and providers. read more By Andrea Park Several lucky startups developing new technologies to transform the medical field are about to get quite a bit richer—$740 million richer, to be exact. read more | 